Psoraisis. Background Pathophysiology, Clinical Manifestation and Treatment

Serum Levels of Plexin B2 in Psoriasis: A case-control study

Role of Interleukin-18, Tumor Necrosis Factor-α, Osteopontin, Paraoxonase and Lipoprotein (a) in Psoriasis Pathogenicity.

The Role Of MicroRNAs In Psoriasis Vulgaris

Study Of Role Of Lipoxin – A4 In Psoriasis

Impact of psoriasis disease and its treatment with Etanercept on serum and saliva thiol-disulfide homeostasis

Role of serum IL-26 in Pathogenesis of Psoriasis vulgaris

Inflammasome NLRP3 Expression in PBMCs and Plasma Interleukin-21 in Psoriasis

Pathogenesis, Treatment and Impact on Quality of Life in Psoriasis

Serum Angiopoietin-2: A Sensitive Inflammatory Marker in Psoriasis Patients